JENNIFER LOPEZ: Open Payments
NPI 1841757085 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,064 in 63 payments from 12 companies in 2025. Trend: 2023 $1,098 · 2024 $1,158 · 2025 $2,064
Food & beverage: $2,064
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $491 |
| Lilly USA, LLC | 13 | $360 |
| Novo Nordisk Inc | 13 | $270 |
| Optinose US, Inc. | 2 | $264 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $156 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| PFIZER INC. | 4 | $100 |
| Amgen Inc. | 2 | $100 |
| Exact Sciences Corporation | 4 | $89 |
| ABBVIE INC. | 2 | $53 |
Products named: FREESTYLE LIBRE 3, Xhance, Wegovy, XIFAXAN, KISUNLA, ZEPBOUND, BREZTRI, ELIQUIS.
Industry payments across TX — which companies pay providers there.
